Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson’s disease: a systematic review and meta-analysis - Jiang, De-Qi; Zang, Qing-Min; Jiang, Li-Lin; Wang, Yan; Li, Ming-Xing; Qiao, Jing-Yi (Naunyn-Schmiedeberg's archives of pharmacology, 2021)
Keywords: Activities of daily living; Adverse events; Antiparkinson Agents - administration & dosage; Antiparkinson Agents - pharmacology; Benserazide - administration & dosage; Benserazide - pharmacology; Biomedical and Life Sciences; Biomedicine; Clinical trials; Combination therapy; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Levodopa - administration & dosage; Levodopa - pharmacology; Meta-analysis; Movement disorders; Neurodegenerative diseases; Neurosciences; Original Article; Parkinson Disease - drug therapy; Parkinson's disease; Patients; Pharmacology/Toxicology; Pramipexole; Pramipexole - administration & dosage; Pramipexole - pharmacology; Randomized Controlled Trials as Topic; Sensitivity analysis; Treatment Outcome; UPDRS; Levodopa; Safety; Parkinson’s disease; Pramipexole; Meta-analysis